Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide soft capsules for aphasia after cerebral infarction
ChiCTR2000040730Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in aphasia and brain infarction comparing Control group (placebo) with Experimental group (butylphthalide soft capsules) (2 arms). Primary endpoint: Western Aphasia Battery Aphasia Quotient. Started Dec 2020; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
aphasiabrain infarction
Beyond the preview
Go deeper on ChiCTR2000040730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040730.